Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Investing Profile

Andrew Hack

InvestorVC
Managing Director at Bain Capital Life Sciences
baincapital.comBoston, Massachusetts
Bain Capital Life Sciences Managing Director
$100K - $5.0M
$1.5M
8
CompanyStageDateRound SizeTotal Raised
Merida Biosciences
Series AApr 2025$120M
$120M
Co-investors: Reid Huber (Third Rock Ventures), Abbie Celniker (Third Rock Ventures)
JenaValve Technology
Series CAug 2022$100M
Series UnknownFeb 2020$50M
$270M
Co-investors: Olivier Litzka (Andera Partners), Peter Barrett (Atlas Venture)
Nuvalent
Series BMay 2021$140M
$190M
Co-investors: Cameron Wheeler (Deerfield Management)
Xilio Therapeutics
Series CFeb 2021$95M
$330M
Co-investors: Peter Dudek (MRL Ventures Fund), Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Nancy Hong (RiverVest), Jack Kenney (SV Health Investors)
Affinivax
Series CJan 2021$230M
Series BApr 2020$120M
$350M
Co-investors: Dorothy Margolskee (Foresite Capital)
Atea Pharmaceuticals
Series DMay 2020$220M
$220M